Department of Health and Human Services November 23, 2012 – Federal Register Recent Federal Regulation Documents

Medicare Program; Town Hall Meeting on FY 2014 Applications for New Medical Services and Technology Add-On Payments
Document Number: 2012-28478
Type: Notice
Date: 2012-11-23
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This notice announces a Town Hall meeting in accordance with section 1886(d)(5)(K)(viii) of the Social Security Act (the Act) to discuss fiscal year (FY) 2014 applications for add-on payments for new medical services and technologies under the hospital inpatient prospective payment system (IPPS). Interested parties are invited to this meeting to present their comments, recommendations, and data regarding whether the FY 2014 new medical services and technologies applications meet the substantial clinical improvement criterion.
Recognition of Entities for the Accreditation of Qualified Health Plans
Document Number: 2012-28440
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services
This notice announces the recognition of the National Committee for Quality Assurance (NCQA) and URAC as recognized accrediting entities for the purposes of fulfilling the accreditation requirement as part of qualified health plan certification.
Provisions of the Food and Drug Administration Safety and Innovation Act Related to Medical Gases; Establishment of a Public Docket
Document Number: 2012-28431
Type: Notice
Date: 2012-11-23
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is establishing a public docket for information pertaining to FDA's implementation of the provisions of the Food and Drug Administration Safety and Innovation Act (FDASIA) related to medical gases. This action is intended to ensure that information submitted to FDA on the implementation of the medical gas provisions of FDASIA is available to all interested persons in a timely fashion.
Draft Guidance for Industry on Vaginal Microbicides: Development for the Prevention of Human Immunodeficiency Virus Infection; Availability
Document Number: 2012-28430
Type: Notice
Date: 2012-11-23
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Vaginal Microbicides: Development for the Prevention of HIV Infection.'' The purpose of this guidance is to assist sponsors in all phases of development of vaginal microbicides for the prevention of human immunodeficiency virus (HIV) infection. The guidance outlines the types of nonclinical studies and clinical trials recommended throughout the drug development process to support approval of vaginal microbicides.
Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting
Document Number: 2012-28378
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, Health Resources and Service Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
Document Number: 2012-28377
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, Health Resources and Services Administration
National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting
Document Number: 2012-28374
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 2012-28373
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services
National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting
Document Number: 2012-28371
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 2012-28370
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Document Number: 2012-28369
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services
Center for Scientific Review; Amended Notice of Meeting
Document Number: 2012-28368
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting
Document Number: 2012-28367
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Information Collection Activity; Comment Request
Document Number: 2012-28340
Type: Notice
Date: 2012-11-23
Agency: Department of Health and Human Services, Administration for Children and Families
Guidance for Industry and Food and Drug Administration Staff; The Content of Investigational Device Exemption and Premarket Approval Applications for Artificial Pancreas Device Systems; Availability
Document Number: 2012-28339
Type: Notice
Date: 2012-11-23
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled ``The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems.'' FDA is issuing this guidance to inform industry and Agency staff of its recommendations for analytical and clinical performance studies to support premarket submissions for artificial pancreas systems.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.